🇺🇸 FDA
Pipeline program

SION-719

SION-719-201

Phase 2 small_molecule active

Quick answer

SION-719 for Cystic Fibrosis (CF) is a Phase 2 program (small_molecule) at Sionna Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Sionna Therapeutics
Indication
Cystic Fibrosis (CF)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials